(2018). Merck Sharp & Dohme Corp. v. Amneal Pharmaceuticals LLCUnited States Court of Appeals of the Federal Circuit, 2018881 F.3d 1376. Biotechnology Law Report, 37(2), 109. https://doi.org/10.1089/blr.2018.29066.cmh
Chicago Style (17th ed.) Citation"Merck Sharp & Dohme Corp. V. Amneal Pharmaceuticals LLCUnited States Court of Appeals of the Federal Circuit, 2018881 F.3d 1376." Biotechnology Law Report 37, no. 2 (2018): 109. https://doi.org/10.1089/blr.2018.29066.cmh.
MLA (9th ed.) Citation"Merck Sharp & Dohme Corp. V. Amneal Pharmaceuticals LLCUnited States Court of Appeals of the Federal Circuit, 2018881 F.3d 1376." Biotechnology Law Report, vol. 37, no. 2, 2018, p. 109, https://doi.org/10.1089/blr.2018.29066.cmh.
Warning: These citations may not always be 100% accurate.
